Inhaled NO as an Anti-inflammatory and Anti-reperfusion Agent in Infants and Children Undergoing Cardiopulmonary Bypass

NCT00585013 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

17

Enrollment

OTHER

Sponsor class

Conditions

Congenital Heart Disease

Interventions

DRUG: Nitric Oxide

Sponsor

Washington University School of Medicine

Collaborators

[object Object]